Nichols David Wayne 4
4 · Magenta Therapeutics, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Nichols David Wayne
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-08-01+75,000→ 75,000 totalExercise: $1.57Exp: 2032-07-31→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on the first quarter following the vesting commencement date. The vesting commencement date is August 1, 2022.